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Background: Research has demonstrated an association between exposure to early life stress and an increased risk
of psychiatric disorders in later life, in particular depression. However, the mechanism through which early life stress
contributes to disease development remains unclear. Previous studies have reported an association between early
life stress and altered methylation of the serotonin transporter gene (SLC6A4), a key candidate gene for several
psychiatric disorders. These differences in methylation are influenced by sex and genetic variation in the SLC6A4-
linked polymorphic region (5-HTTLPR). Furthermore, one study indicated that stress during pregnancy may induce
methylation changes in SLC6A4 in the newborn. The present study is the first to investigate whether early life stress
during pregnancy impacts on SLC6A4 methylation in newborns, taking into account the influence of genetic
variation and sex.
Methods: Cord blood was obtained from newborns with high (n = 45) or low (n = 45) early life stress, defined as
maternal stress during pregnancy. The effect on methylation of early life stress, 5-HTTLPR genotype, and sex was
assessed at four cytosin-phosphate-guanine dinucleotide (CpG) sites in the promoter associated CpG island north
shore (CpG 1 to 4). The epigenetic analyses focused on these CpG sites, since research has shown that CpG island
shore methylation has functional consequences.
Results: Significant sex-specific methylation was observed, with females displaying higher methylation levels than
males (p < 0.001). Importantly, this effect was influenced by neither early life stress nor genotype.
Conclusions: The present data suggest that sex-specific methylation of SLC6A4 is present at birth, and is independent
of early life stress and 5-HTTLPR genotype. This may contribute to the sex-specific prevalence of depression.
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The serotonin transporter gene (SLC6A4) is one of the
most extensively investigated genes in psychiatry, and
has been implicated in a wide range of psychiatric disor-
ders [1]. Research has shown that variation in this gene
is associated with stress-related psychiatric disorders,
such as major depression and anxiety [2]. The most con-
sistently reported association is with variation in the* Correspondence: helene.dukal@zi-mannheim.de
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unless otherwise stated.SLC6A4-linked polymorphic region (5-HTTLPR). This
5-HTTLPR consists of a 44-base-pair insertion/deletion
polymorphism in the 5′ regulatory promoter region of
SLC6A4, which results in a short (S) and long (L) allele
of the gene and a single nucleotide polymorphism in the
L allele of 5-HTTLPR (rs25531 A/G) which leads to a
triallelic locus (S/LA/LG) [3]. The S allele has been
reported to reduce transcriptional activity of the gene
promoter in vitro, and to be associated with depression-
related personality traits [4,5]. Moreover, research has
identified a gene x environment interaction for life stress
and the 5-HTTLPR genotype in adults with depression
[6]. In comparison to L homozygotes, S allele carriershis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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able depression, and suicidality.
Furthermore, numerous studies have demonstrated
methylation differences in SLC6A4 in individuals with
depressive symptoms [7], depression [8], and a history of
early life stress [9-14]. Sex- [8,9] and genotype-effects
have also been described [10-12].
Several studies have demonstrated that early life stress
has a major impact on mental health in later life. Child-
hood adversity is associated with increased vulnerability
to several psychiatric disorders, in particular mood, anx-
iety, and personality disorders [15]. Furthermore, mater-
nal stress during pregnancy has been associated with
distinct behavioral disturbances in the offspring in later
life [16]. In particular, maternal stress during pregnancy
appears to have major effects on the stress response and
the propensity to depression in the offspring [17]. To
date, only one study has analyzed the influence of
depressed maternal mood during pregnancy on sero-
tonin transporter methylation levels in the newborn. In
this study, increased 2nd trimester depressed maternal
mood was associated with decreased maternal and infant
serotonin transporter promoter methylation [18]. How-
ever, the authors did not take into account the possible
effect of variation in 5-HTTLPR genotype and sex.
A previous study has shown that methylation of
SLC6A4 CpG island shore CpG sites has functional con-
sequences [19]. Generally, methylation of DNA cytosines
in the context of cytosin-phosphate-guanine (CpG) di-
nucleotides is a covalent modification of DNA with a
methyl group. The latter is introduced into the DNA by
an enzymatic reaction catalyzed by DNA methyltrans-
ferases [20]. CpG dinucleotides are often clustered in
CpG islands at the promoter region of genes. In general,
methylation leads to gene silencing via reduced trancrip-
tional activity [21]. Previous authors have hypothesized
that early life adversity results in DNA methylation and
life-long phenotypes [20].
Therefore, the aims of the present study were to deter-
mine 1) whether exposure to maternal stress during
pregnancy leads to higher methylation levels in SLC6A4
in newborns; and 2) whether this is influenced by sex
and 5-HTTLPR genotype. The analyses focused on four
previously reported functional serotonin transporter
gene CpG island north shore CpG sites [19].
Methods
Study participants
Data were obtained from a cohort of mothers and their
infants (n=410), respectively recruited during the third
trimester of pregnancy (4–8 weeks prior to term) from
the Rhine-Neckar Region of Germany. The study proto-
col was approved by the Ethics Committee of the Med-
ical Faculty Mannheim of the University of Heidelberg.The study was conducted in accordance with the
Declaration of Helsinki. All mothers provided written in-
formed consent prior to participation. A structured
interview and questionnaires were used for risk factor
assessment. Inclusion criteria for mothers were: main
caregiver; German-speaking; and age 16–40 years. Exclu-
sion criteria for mothers were: hepatitis B, hepatitis C, or
human immunodeficiency virus (HIV) infection; any
current psychiatric disorder requiring inpatient treatment;
any history or current diagnosis of schizophrenia/psych-
otic disorder; or any substance dependency other than
nicotine during pregnancy. Exclusion criteria for infants
were: birth weight < 1,500 gram; gestational age < 32 weeks;
or the presence of any congenital diseases, malformations,
deformations, and/or chromosomal abnormalities.
A broad range of environmental and sociodemo-graphic
risk factors, prenatal medical risk factors, general medical
characteristics, and psychosocial risk factors were assessed
(Table 1). Eight main stressor variables were derived from
eight different questionnaires (Perceived stress scale [PSS],
Prenatal distress questionnaire [PDQ], Life experiences
survey [LES], Social support questionnaire [SOZ_U],
Mini-International Neuropsychiatric Interview [M.I.N.I.],
Edinburgh postnatal depression scale [EPDS], State-trait
anxiety inventory [STAI-S & STAI-T], Anxiety screening
questionnaire [ASQ]) in order to represent a variety of
prenatal adversities and to take the following three
dimensions of stress into account: a) maternal psycho-
pathology (primarily depressive and anxious symp-
toms); b) perceived stress; and c) socioeconomic and
psychosocial stress. All data were assessed at two time-
points: in the 3rd trimester and at birth (see Table 1 and
Additional file 1 for details). In addition, an “adversity
score” was calculated. This was obtained by summing up
all positive responses to the following 12 stressful dichot-
omous (yes/no) stressful adverse prenatal conditions and
environmental circumstances: 1) current and lifetime M.
I.N.I. (Mini International Neuropsychiatric Interview)
diagnosis; 2) current psychiatric diagnosis; 3) not cohab-
iting with partner; 4) low levels of encouragement from
the partner; 5) separation(s) in the last year; 6) daily
verbal conflict; 7) physical conflict; 8) crowded living
conditions (≤ one room/person); 9) no academic quali-
fication; 10) no professional education; 11) low net
family income; and 12) debt (see Table 2 for details).
Further information on demographic variables is pro-
vided in (Additional file 2: Table 1).
To obtain a homogeneous composite measure of pre-
natal stress, a principal component analysis (PCA) was
performed using the eight main stressor variables and
the total adversity score. This yielded a first principal
component (PC1) that explained around 60% of the
common variance. PC1 was then used to determine two
extreme groups: 45 infants (24 females; 21 males) with
Table 1 Phenotypic assessment of mothers and infants at two time points
Prenatal/3rd trimester Perinatal/birth
Exposure to ELS Perceived stress (PSS) [33] Pre- and perinatal complications
Prenatal distress (PDQ) [34] Perinatal stressors (e.g., asphyxia, cesarian, preterm birth)
Life events (LES) [35] Pregnancy & obstetric history (birth weight, gestational age,
birth complications)
Social support (Soz-U.) [36]
Socio-demographic data
Maternal health risk behavior (e.g. smoking)
Psychosocial risks





Depression screening (EPDS) [38]
Anxiety screening (STAI-S [39], STAI-T [39], ASQ [40])
Anthropometry
Individual & family history of metabolic and other
medical disorders
ELS = early life stress; PSS = perceived stress scale; PDQ = prenatal distress questionnaire; LES = life experiences survey; Soz-U = social support questionnaire;
M.I.N.I. = Mini-international neuropsychiatric interview; EPDS = Edinburgh postnatal depression scale; STAI-S & STAI-T = state-trait anxiety inventory; ASQ = anxiety
screening questionnaire.
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infants (27 females; 18 males) with extremely low levels
of prenatal early life stress [22].
Demographic characteristics included in the methyla-
tion analysis were maternal age (maternal age high pre-
natal stress, 29.60 ± 5.61; maternal age low prenatal
stress, 32.73 ± 3.69) and the sex of the newborn (high
prenatal stress female 53.3%; low prenatal stress female
60%).
5-HTTLPR rs25531 multimarker genotyping
Simultaneous genotyping of 5-HTTLPR and rs25531
was carried out by polymerase chain reaction (PCR)
according to Wendland et al. [23]. In a total volume of
20 μl, 60 ng of genomic DNA was amplified in the
presence of 1 x Master Mix (Promega) using the fol-
lowing primers: forward primer: 5′-TCCTCCGCTTTG
GCGCCTCTTCC-3′; reverse primer: 5′-TGGGGGTT
GCAGGGGAGATCCTG-3′. The PCR conditions were:
5 minutes at 95°C, followed by 35 cycles of 30 seconds
at 95°C, 90 seconds at 70°C, 60 seconds at 72°C, and
a final extension of 10 minutes at 72°C. Subsequently,
complete PCR product was digested with HpaII (New
Enlgand Biolabs) in a 25 μl reaction assay containing
1xNEBuffer 1 at 37°C for 4 h. Then, 15 μl of the
digested PCR products were run on a 2.5% agarose gel
and visualized with ethidium bromide staining. For the
5-HTTLRP L allele, a band of 512 basepairs (rs25531,
A allele, uncut) or 402 basepairs and 110 basepairs
(rs25531, G allele, cut) was visible. For the 5-HTTLRP
S allele, a band of 469 basepairs was visible. The 5-
HTTLPR rs25531 multimarker genotype is combinedaccording to its SLC6A4 mRNA expression into high
expressing genotype 5-HTTLPR LA and low express-
ing genotype 5-HTTLPR S and LG.Methylation analysis
Ethylenediaminetetraacetic umbilical blood samples were
obtained from all participants. Automated genomic DNA
extraction was performed using the chemagic Magnetic
Separation Module I (Chemagen Biopolymer-Technologie
AG; Baesweiler; Germany). Genomic DNA samples
(500 ng) from 90 individuals were bisulfit-treated using
the EpiTect Bisulfite Kit (Qiagen, Hilden, Germany), and
stored at −20°C prior to analysis. To obtain results
comparable to those of earlier studies, the analysis fo-
cused on four of the five CpG sites described by Sugawara
et al. [19]. These are located in the promoter associated
CpG island north shore (Figure 1), and island shore
methylation in general is likely to be related to gene ex-
pression [24]. Methylation at the analyzed region shows
high variance ([25], data set 11 validation analysis module
via MarmalAid-database). The CpG site two in the
present study corresponds to the CpG Site cg22584138
from the Illumina HumanMethylation450 BeadChip. A
fragment of 204 basepairs of the serotonin transporter
gene SLC6A4 (NG_011747.2) was amplified from 2 μl
bisulfit-treated DNA using PCR (HotStar Taq DNA
Polymerase, Qiagen, Hilden, Germany) and the forward
primer 5′-TTTTTAGTTGTTTGGGTATTTGTGTTA-
3′ and the reverse primer 5′-AAAACTTTACAACCT
CTTAAAAACCC-3′. A biotin was located at the 5′
end of the reverse primer (Eurofins/MWG/Operon,
Figure 1 Schematic overview and sequence of SLC6A4 promoter associated CpG island region. The positions refer to GeneBank accession number
NG_011747.2. The numbers 1 to 4 refer to locations of the CpG sites assayed in the present study. CpG site 2 corresponds to CpG site cg22584138.
(5-HTTLPR = SLC6A4-linked polymorphic region, S shore = South shore of CpG island, CpG island = cytosin-phosphate-guanine island, N shore = North
shore of CpG island).
Table 2 Psychopathology and socioeconomic-, psychosocial-, and perceived stress of the extreme group mothers
(all data: mean ± SD or percentage)
Variable High prenatal ELS (n = 45) Low prenatal ELS (n = 45) p value
Maternal psychopathology
EPDS Score1 12.33 ± 4.70 1.27 ± 1.45 0.000
STAI-S Score1 51.72 ± 8.05 27.41 ± 3.87 0.000
STAI-T Score1 47.93 ± 8.41 28.04 ± 3.58 0.000
ASQ Score1 4.11 ± 2.14 0.53 ± 0.72 0.000
M.I.N.I. Diagnosis2
None 51.1% 91.1% 0.004
Depressive disorder 40% 6.7% 0.015
Anxiety disorder 8.9% 2.2% ns
Current psychiatric disorder2
None 62.2% 97.8% 0.005
Depressive disorder 26.7% 0% 0.015
Anxiety disorder 11% 2.2% ns
Perceived stress
PSS Score1 30.84 ± 5.64 12.84 ± 4.1 0.000
PDQ Score1 19.95 ± 7.56 5.95 ± 2.95 0.000
Socioeconomic and psychosocial stress
LES-negative events Score1 6.75 ± 4.39 1.80 ± 1.29 0.010
Soz-U Score1 39.58 ± 3.85 51.89 ± 4.32 0.000
Living without a partner2 20% 0% 0.004
Encouragement (Partner)2 73.3% 100% ns
Separation(s) in the last year2 24.4% 2.2% 0.002
Daily arguments2 11.1% 2.2% ns
Physical conflicts within the preceding 12 months2 33.3% 2.2% 0.003
Composition of household > one person/room2 40.5% 0% 0.001
No academic qualification2 4.4% 2.2% 0.050
No professional education2 17.7% 2.2% 0.043
Monthly income per household ≤ 1,750 Euro2 42.2% 0% 0.001
Debt2 24.4% 2.2% 0.002
SD = standard deviation; ns = not significant. 1The first eight main variables of the principal component analysis (PCA), 2The twelve prenatal stressors used to
generate the adversity score as the ninth main variable of the PCA.
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product. Cycling parameters were as follows: 95°C for
15 minutes; 50 cycles respectively of 94°C for 30 sec-
onds, 52°C for 30 seconds, and 72°C for 30 seconds;
and a final extension of 10 minutes at 72°C. PCR
products were pyrosequenced using the PyroMark Q24
system (Qiagen, Hilden, Germany) and the primers 5′-
TTTTGTATAAAGTTATTTGT-3′ (CpG 1 and 2), and
5′-AATATAAATTATGGGTTGAA-3′ (CpG 3 and 4).
Methylated and unmethylated EpiTect control DNA sam-
ples (Qiagen, Hilden, Germany) were used as controls for
the bisulfite conversion reaction, the amplification, and
the pyrosequencing reaction. Successful amplification and
the specificity of the PCR products were checked on an
agarose gel. Processing of the PCR amplicons for the py-
rosequencing analysis was performed in accordance with
the manufacturer’s protocol (Qiagen, Hilden, Germany).
The percentage of methylation at each CpG site was
quantified using the Pyro Q-CpG software, version 2.0.6
(Qiagen, Hilden, Germany). Methylation levels were
defined in terms of the percentage of methylated DNA, as
indicated by the Pyro-Q software. All measurements were
made in triplicate. Values marked as unreliable by the
Pyro-Q software, and values deviating by >3%-points
from other replicates, were discarded. The remaining
replicates were averaged.
Statistical analysis
Two-tailed t-tests for independent samples (SPSS® Statis-
tics 20) were used to compare demographic factors
between the extreme groups. Nominal significance was
set at α = 0.05. Data and results are expressed as means ±
standard deviation (SD) or as percentages, as appropriate
[22]. Quality control and association testing of methyla-
tion data were performed using the R 2.15.3 softwareFigure 2 Sex specific mean SLC6A4 methylation. Females shown in ligh
Asterisks indicate significance.package (http://www.r-project.org). Association tests were
performed using multifactorial ANOVA models which
included all variables of interest with correction for plate
effects. Tests were performed for each of the four sites
and for the mean of all four sites.Results
All individuals were genotyped successfully. This yielded
genotype counts of 21 (LA/LA); 7 (LA/LG); 44 (LA/SA);
1 (LG/SA); and 17 (SA/SA). The genotype frequencies
were LA/LA, 23.3%; LA/LG, 7.7%; LA/SA, 48.8%; LG/
SA, 1.1% and SA/SA, 18.9%. The genotype distributions
of 5-HTTLPR and of the combined 5-HTTLPR-rs25531
genotypes were in accordance with Hardy-Weinberg-
Equilibrium (pexact = 1; pexact = 0.23). During quality
control, 18 methylation measurements were discarded
due to high variance. Multifactorial linear modeling in-
volving simultaneous incorporation of the sex of the
newborn, 5-HTTLPR genotype, and early life stress
(high early life stress level: n = 24 females and n = 21
males, low early life stress level: n = 27 females and n =
18 males) revealed that only the sex of the newborn was
associated with methylation level (mean methylation,
p = 7.5 × 10−10). No association was found for geno-
type (mean methylation, p = 0.75) or early life stress
(mean methylation, p = 0.94). On average, females (mean
methylation x̄=29.3%, standard error of the mean [SEM]
0.5%), showed higher methylation levels than males
(mean methylation x̄=23.8%, SEM 0.5%) (Figure 2). The
mean percentage of DNA methylation across all four
CpG sites was: 1) 26.5%, SEM 0.5%, for the low ELS
group; and 2) 26.5%, SEM 0.5%, for the high ELS group
(p = 0.94) (Table 3). In a secondary analysis, information
on rs25531 was integrated. Combined 5-HTTLPR-t gray, males in dark gray, mean in % +/- standard error of the mean.
Table 3 P-values and r-squared values (in parentheses) obtained from multi factorial ANOVA models of the effect of
sex, ELS, and 5-HTTLPR genotype on SLC6A4 methylation
CpG site
Predictor in model 1 2 3 4 Mean across sites
Sex 3.9e-08 (0.302) 2.3e-09 (0.361) 1.2e-07 (0.288) 3.7e-08 (0.311) 7.5e-10 (0.371)
ELS 0.94 (0.000) 0.67 (0.004) 0.92 (0.001) 0.96 (0.000) 0.94 (0.001)
Genotype 0.12 (0.070) 0.47 (0.028) 0.95 (0.005) 0.72 (0.027) 0.75 (0.025)
Sex x ELS 0.76 (0.001) 0.33 (0.006) 0.78 (0.003) 0.56 (0.003) 0.63 (0.002)
Sex x Genotype 0.50 (0.011) 0.61 (0.008) 0.73 (0.004) 0.51 (0.011) 0.57 (0.008)
ELS x Genotype 0.79 (0.003) 0.41 (0.013) 0.44 (0.012) 0.74 (0.005) 0.52 (0.009)
Significant p-values are shown in bold. ELS = early life stress; 5-HTTLPR genotype = SLC6A4-linked polymorphic region genotype.
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ing according to Wendland et al. [23]. This analysis
revealed no evidence for a genotype effect, or any inter-
action between genotype and other predictors in the
model (Table 4).
Discussion
The aims of the present study were to determine whether
exposure to early life stress – defined as maternal stress
during pregnancy – impacts SLC6A4 methylation levels
in newborns, and whether this is influenced by sex or
5-HTTLPR genotype. In the present cohort, methyla-
tion was influenced by sex, but not by early life stress
or 5-HTTLPR genotype. Following the integration of
the effects of rs25531, which has been reported to
influence expression of SLC6A4 [23], the results were
unaltered.
Research has shown that DNA methylation can lead to
persistent alterations in gene function, and that this may
result in a range of psychiatric phenotypes [20]. Robust
data suggest that stress has an influence on methylation,
and higher SLC6A4 methylation has been associated
with reduced gene expression [26]. In individuals with
the S/S genotype of 5-HTTLPR, Sugawara et al. found
an inverse correlation between SLC6A4 methylation
levels and gene expression [19]. Several earlier studies
had demonstrated that early life stress-inducedTable 4 P-values and r-squared values (in parentheses) obtaine
ELS, and combined 5-HTTLPR rs25531 genotype grouped acco
CpG site
Predictor in model 1 2
Sex 4.5e-08 (0.300) 1.4e-09 (0.367)
ELS 0.82 (0.000) 0.68 (0.004)
Genotype_HL 0.11 (0.074) 0.83 (0.017)
Sex x ELS 0.69 (0.001) 0.43 (0.005)
Sex x Genotype_HL 0.67 (0.006) 0.65 (0.007)
ELS x Genotype_HL 0.81 (0.003) 0.58 (0.009)
Significant p-values are shown in bold. ELS = early life stress; Genotype_HL = 5-HTTL
according to Wendland et al. [23].methylation differences were influenced by genetic
variation in 5-HTTLPR genotype. In the Iowa adoptee
sample, early adversity was associated with differential
methylation, as mediated by 5-HTTLPR genotype [9-12].
As reported with high SLC6A4 methylation, the S
allele of the 5-HTTLPR genotype leads to decreased
gene expression, and has been repeatedly associated with
an increased vulnerability for stress-related psychiatric
disorders, such as depression and anxiety [6]. However,
the present study analyzed different CpG sites, and thus
cross-study comparison of results is problematic. The
present study focused on the functional CpG sites re-
ported by Sugawara et al. [19]. These were selected on
the basis of their promising position in the island north
shore and their reported functionality.
Sensitivity to stress changes throughout the life-span,
and young adults with a history of stressful life events
during the first five years of life show a particularly pro-
nounced stress response [27]. Therefore we expected
individuals exposed to stress during an even earlier
period of life to show increased methlyation compared
to those with no history of exposure. Interestingly, how-
ever, in the present cohort, neither early life stress nor
genotype influenced methylation in utero.
However, a strong sex-effect was apparent, and recent
studies have generated independent evidence for an
effect of sex on SLC6A4. Wang et al. reported that atd from multi factorial ANOVA models of the effect of sex,
rding to Wendland et al. [23] on SLC6A4methylation
3 4 Mean across sites
9.7e-08 (0.286) 3.9e-08 (0.310) 6.3e-10 (0.371)
0.86 (0.001) 0.87 (0.000) 0.98 (0.001)
0.66 (0.015) 0.68 (0.030) 0.76 (0.027)
0.66 (0.003) 0.56 (0.003) 0.69 (0.001)
0.67 (0.006) 0.81 (0.004) 0.71 (0.005)
0.77 (0.004) 0.84 (0.004) 0.74 (0.005)
PR rs25531 multi marker genotype, _HL = _HighLow genotype grouping
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than in males [28]. In a longitudinal assesssment of their
cohort, the authors found persistent sex-differences two
years after birth. In another study, Xu et al. found sex
differences in this CpG site in the post-mortem adult
brain [29]. Neither of these studies, however, had taken
into account early life stress or 5-HTTLPR genotype.
Sex specific DNA methylation, i.e., other than that
occurring during the X-inactivation process, has been
demonstrated in a number of locus-specific ([30]) and
genome-wide analyses (e.g. [31]). This could represent a
mechanism underlying the differential susceptibility to
psychiatric disorders observed between males and fe-
males [32]. Further studies are warranted to determine
both whether these methylation differences are perman-
ent, and the contributory factors.
Conclusions
To our knowledge, the present study is the first to
demonstrate sex-determined methylation of SLC6A4 in
newborns, irrespective of early life stress status and 5-
HTTLPR genotype. Given the previously reported func-
tionality of SLC6A4 methylation and the importance of
the serotonin transporter (5-HTT) in depression, higher
methylation levels during early life may contribute to the
increased risk for depression observed among females.
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